Valuation Crossject Deutsche Boerse AG
Stocks
74C
FR0011716265
Medical Equipment, Supplies & Distribution
|
Market Closed -
Deutsche Boerse AG
10:01:23 21/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 1.422 EUR | -0.14% |
|
-0.97% | -31.14% |
| 05-26 | Crossject: The last round of financing? | AL |
| 05-25 | Crossject buoyed by Oddo BHF note following capital hike |  |
Company Valuation: Crossject
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 78.44 | 99.04 | 189 | 104.5 | 115.5 | 76.87 | - | - |
| Change | - | 26.25% | 90.83% | -44.71% | 10.53% | -33.44% | - | - |
| Enterprise Value (EV) 1 | 88.99 | 105.4 | 205.6 | 118.5 | 115.5 | 58.97 | 29.87 | -5.525 |
| Change | - | 18.43% | 95.08% | -42.35% | -2.56% | -48.94% | -49.34% | -118.5% |
| P/E | -6.95x | -11x | -21.6x | -7.93x | -11.5x | 3.44x | 2.72x | 1.96x |
| PBR | -13.4x | 44.6x | -35.7x | -49.2x | - | 2.57x | 1.38x | 0.89x |
| PEG | - | 0.4x | 0.9x | -0.4x | 0.4x | -0x | 0.1x | 0.1x |
| Capitalization / Revenue | 86x | 104x | 14.7x | 7.88x | 7.76x | 1.26x | 1.82x | 1.38x |
| EV / Revenue | 97.6x | 110x | 16x | 8.94x | 7.76x | 0.97x | 0.71x | -0.1x |
| EV / EBITDA | -12.1x | -15.2x | -33.6x | -14.6x | - | 1.45x | 0.64x | -0.1x |
| EV / EBIT | -7.53x | -7.93x | -16.7x | -9.14x | -9.95x | 1.56x | 2.5x | -0.1x |
| EV / FCF | - | - | -16.3x | -10.3x | -10.6x | 2.49x | 4.27x | -0.14x |
| FCF Yield | - | - | -6.13% | -9.69% | -9.39% | 40.2% | 23.4% | -706% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.41 | -0.3 | -0.23 | -0.28 | -0.19 | 0.41 | 0.52 | 0.72 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 0.912 | 0.954 | 12.83 | 13.26 | 14.88 | 60.8 | 42.3 | 55.6 |
| EBITDA 1 | -7.333 | -6.93 | -6.115 | -8.115 | - | 40.8 | 46.7 | 57 |
| EBIT 1 | -11.82 | -13.29 | -12.3 | -12.96 | -11.61 | 37.8 | 11.95 | 53 |
| Net income 1 | - | - | -8.467 | -12.8 | -10.37 | 28.3 | 7.75 | 48.1 |
| Net Debt 1 | 10.55 | 6.356 | 16.62 | 14.03 | - | -17.9 | -47 | -82.4 |
| Reference price 2 | 2.850 | 3.295 | 4.970 | 2.220 | 2.190 | 1.412 | 1.412 | 1.412 |
| Nbr of stocks (in thousands) | 27,523 | 30,057 | 38,026 | 47,070 | 52,740 | 54,444 | - | - |
| Announcement Date | 24/03/22 | 20/03/23 | 02/04/24 | 27/03/25 | 25/03/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -39.98x | 5.3x | -543.62x | - | 122M | |
| 3.44x | 0.97x | 1.45x | - | 89.74M | |
| -5.08x | - | - | - | 59.57M | |
| Average | -13.87x | 3.13x | -271.09x | 90.47M | ||
| Weighted average by Cap. | -17.96x | 3.46x | -312.72x |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ALCJ Stock
- 74C Stock
- Valuation Crossject
Select your edition
All financial news and data tailored to specific country editions
